Hippocampal adenosine A2A receptor up-regulation is necessary and sufficient to trigger memory dysfunction in Alzheimer's disease

被引：0
|
作者：
Cunha, R. [1 ,2 ]
机构：
[1] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
来源：
JOURNAL OF NEUROCHEMISTRY | 2015年 / 134卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WTH12-05
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [31] Cigarette Smoke Impairs A2A Adenosine Receptor Mediated Wound Repair through Up-regulation of Duox-1 Expression
    Zhi Tian
    Hui Zhang
    Jendayi Dixon
    Nicole Traphagen
    Todd A. Wyatt
    Kusum Kharbanda
    Samantha Simet Chadwick
    Narasaiah Kolliputi
    Diane S. Allen-Gipson
    Scientific Reports, 7
  • [32] Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease
    Stoub, Travis R.
    deToledo-Morrell, Leyla
    Stebbins, Glenn T.
    Leurgans, Sue
    Bennett, David A.
    Shah, Raj C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) : 10041 - 10045
  • [33] Association analysis of adenosine A2a receptor 1976T>C polymorphisms and Alzheimer's disease
    Liu, HC
    Hon, CJ
    Liu, TY
    Tsai, SJ
    EUROPEAN NEUROLOGY, 2005, 53 (02) : 99 - 100
  • [34] Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease
    Su, JH
    Satou, T
    Anderson, AJ
    Cotman, CW
    NEUROREPORT, 1996, 7 (02) : 437 - 440
  • [35] Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?
    Jost, Wolfgang H.
    Toenges, Lars
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2022, 90 (12) : 565 - 570
  • [36] Novel therapy in Parkinson's disease: adenosine A2A receptor antagonists
    Szabo, Nikoletta
    Kincses, Zsigmond Tamas
    Vecsei, Laszlo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (04) : 441 - 455
  • [37] A2A adenosine receptor antagonists -: future drugs for Parkinson's disease?
    Müller, CE
    DRUGS OF THE FUTURE, 2000, 25 (10) : 1043 - 1052
  • [38] Adenosine A2A receptor antagonists in Parkinson's disease: still in the running
    Antonini, Angelo
    Poewe, Werner
    LANCET NEUROLOGY, 2014, 13 (08): : 748 - 749
  • [39] Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
    Xu, K
    Bastia, E
    Schwarzschild, M
    PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) : 267 - 310
  • [40] Novel investigational adenosine A2A receptor antagonists for Parkinson's disease
    Pinna, Annalisa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (11) : 1619 - 1631
12345